| 
The Institute for Neurodegenerative Disorders (IND) was formed in
March 2001 as a registered non-profit 501(c)3 research institute
that aims to advance research in Parkinson disease, Alzheimer disease and Huntington disease
through clinical trials and brain imaging. Operating in
New Haven, CT, the Institute stands as a premier research facility
for clinical trials and brain imaging research into neurologic disorders.
The mission of IND is to develop improved treatments, diagnostic
tools and educational programs for neurologic disorders such as
Parkinson disease, Huntington disease, and Alzheimer disease.
IND is comprised of an accomplished team of clinical investigators,
study coordinators, imaging technologists, and radiochemists. This
team is headed by Senior Scientists Kenneth
Marek, MD, John Seibyl, MD, Clinical
Research Director Danna Jennings, MD, and Gilles
Tamagnan, Director of Laboratory Research and Development.
Board of Directors
/ Advisory Board Members
|
|
